More expert researchers are leaving the field or retiring. As the talent pool shrinks, so does our ability to develop the new antibiotics and treatments we urgently need.
How can we reverse this trend?
Hear perspectives from industry, policy and academia on attracting and retaining talent, the role of economic incentives, and how global funding and policy can help build a sustainable, diverse antimicrobial research community.
Speakers:
- Heike Broetz-Oesterhelt, Professor of Microbiology, University of Tuebingen (Germany)
- Marc Lemonnier, CEO of Antabio SAS (France)
- Alexandra Cameron, Senior Technical Officer at WHO (Switzerland)
- Jonathan Stokes, Assistant Professor at the Department of Biochemistry and Biomedical Sciences at McMaster University (Canada)
Moderator:
- Lesley Ogilvie, Secretariat Director at the Global AMR R&D Hub (Germany)
This webinar is organised by GARDP in collaboration with EUP OHAMR.